首页 › 基金 › P2 Capital Partners, LLC › ENOV
P2 Capital Partners, LLC 对 ENOV 的持仓历史
ENOVIS CORPORATION · 医疗保健
P2 Capital Partners, LLC 在 Q3 2026 的 13F 申报中披露持有 ENOV(ENOVIS CORPORATION)320,000 股,市值约 US$5.8M,约占其申报组合的 1.95%,在其申报持仓中市值排名第 14 位。 P2 Capital Partners, LLC 最近 10 个申报季度中有 10 个季度披露了 ENOV 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
P2 Capital Partners, LLC 对 ENOV 的持仓演变
P2 Capital Partners, LLC 于 Q2 2024 首次披露 ENOV 持仓:460,000 股(约 US$20.8M)。 在 10 次申报中,P2 Capital Partners, LLC 1 次增持、3 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 320,000 股、市值约 US$5.8M。 持仓曾出现大幅变动:Q4 2024 减持约 28% (随后一个季度股价下跌 13%)、Q2 2025 增持约 87% (随后一个季度股价下跌 3%)、Q1 2026 减持约 46% (随后一个季度股价下跌 9%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 460.00K | $20.79M | 新进 |
| Q3 2024 | 460.00K | $19.80M | 持有 |
| Q4 2024 | 330.00K | $14.48M | 减持 |
| Q1 2025 | 330.00K | $12.61M | 持有 |
| Q2 2025 | 617.15K | $19.35M | 增持 |
| Q3 2025 | 595.00K | $18.05M | 减持 |
| Q4 2025 | 595.00K | $15.85M | 持有 |
| Q1 2026 | 320.00K | $7.28M | 减持 |
| Q2 2026 | 320.00K | $6.62M | 持有 |
| Q3 2026 | 320.00K | $5.85M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ENOV 与 13F 数据
ENOV(ENOVIS CORPORATION)属于医疗保健行业。我们追踪的基金中还有 17 只申报持有 ENOV,申报仓位最大的包括:Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PRIVATE MANAGEMENT GROUP INC (US$32.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ENOV 的基金
- Rubric Capital Management LP 3.90M 股 · $80.73M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 39.21M 股 · $37.79M · Q2 2026
- PRIVATE MANAGEMENT GROUP INC 1.79M 股 · $32.75M · Q3 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 1.66M 股 · $30.26M · Q3 2026
- Front Street Capital Management, Inc. 1.45M 股 · $26.48M · Q3 2026
更多关于 P2 Capital Partners, LLC
常见问题
How long has P2 Capital Partners, LLC held ENOV?
P2 Capital Partners, LLC has disclosed ENOV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is P2 Capital Partners, LLC's current position in ENOV?
As of Q3 2026, P2 Capital Partners, LLC holds 320.00K shares of ENOV (ENOVIS CORPORATION), valued at $5.85M, representing 1.95% of its reported portfolio and ranking #14.
Has P2 Capital Partners, LLC been buying or selling ENOV?
In the latest 13F filing (Q3 2026), P2 Capital Partners, LLC held unchanged its position in ENOV.
Which other funds hold ENOV?
Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PRIVATE MANAGEMENT GROUP INC, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.